Swiss Biotech Lonza Pays Up To $300M For Ingredients Maker
Swiss biotechnology firm Lonza Group AG has agreed to buy dietary supplement ingredients maker InterHealth Nutraceuticals Inc. from private equity firm Kainos Capital LLC in a deal that could be worth...To view the full article, register now.
Already a subscriber? Click here to view full article